Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Human Heredity is Scopus-indexed (Q3, CiteScore 2.2), WoS SCIE, DOAJ. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 0001-5652Verify ISSN ↗1423-0062Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics (clinical) | 74 / 100 | 26th | Q3 |
| Genetics | 286 / 357 | 20th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1956–present (also 1950–1954), best quartile Q3, CiteScore 2.2.
Human Heredity is Q3 in Genetics (clinical) (rank 74 of 100) and Q4 in Genetics (rank 286 of 357), by CiteScore 2025.
Human Heredity is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.2, which places it in quartile Q3 at the 26th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.265, quartile Q4, with an H-index of 67.
Human Heredity is published by S. Karger AG. Its print ISSN is 0001-5652 and its online ISSN is 1423-0062.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Human Heredity has an h-index of 95 and a 2-year mean of 0.67 citations per paper (OpenAlex). Its Scopus CiteScore is 2.2, quartile Q3. On 2-year citations it ranks #80 of 99 Scopus journals in Genetics (clinical).
Human Heredity published 10 papers in 2025; its busiest recent year was 2018 with 31. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 41 research articles (2021–2026), authors are most often from China (44.7%), United Kingdom (11%) and United States (10.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.